All posts tagged head-and-neck cancer

  • Rare genetic disease offers insight into common cancers

    Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing a variety of cancers, especially leukemias and head and neck cancer.

Cancer trials at the Denver VA expand thanks to an expanded collaboration with the CU Cancer Center
Antonio Jimeno, MD, PhD, investigator at the University of Colorado Cancer Center
Pat & Myka Landry, CU Cancer Center patient and caregiver.
Dr. Antonio Jimeno with patient Katrina, who is doing well on an anti-stem cell treatment